459 related articles for article (PubMed ID: 14606929)
1. Principles and clinical application of assessing alterations in renal elimination pathways.
Tett SE; Kirkpatrick CM; Gross AS; McLachlan AJ
Clin Pharmacokinet; 2003; 42(14):1193-211. PubMed ID: 14606929
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.
Gross AS; McLachlan AJ; Minns I; Beal JB; Tett SE
Br J Clin Pharmacol; 2001 Jun; 51(6):547-55. PubMed ID: 11422014
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
Verbeeck RK; Musuamba FT
Eur J Clin Pharmacol; 2009 Aug; 65(8):757-73. PubMed ID: 19543887
[TBL] [Abstract][Full Text] [Related]
4. Principles of drug administration in renal insufficiency.
Lam YW; Banerji S; Hatfield C; Talbert RL
Clin Pharmacokinet; 1997 Jan; 32(1):30-57. PubMed ID: 9012555
[TBL] [Abstract][Full Text] [Related]
5. Analytical validation for a series of marker compounds used to assess renal drug elimination processes.
McLachlan AJ; Gross AS; Beal JL; Minns I; Tett SE
Ther Drug Monit; 2001 Feb; 23(1):39-46. PubMed ID: 11206041
[TBL] [Abstract][Full Text] [Related]
6. Saturable pharmacokinetics in the renal excretion of drugs.
van Ginneken CA; Russel FG
Clin Pharmacokinet; 1989 Jan; 16(1):38-54. PubMed ID: 2650954
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and clinical implications of renal drug excretion.
Masereeuw R; Russel FG
Drug Metab Rev; 2001; 33(3-4):299-351. PubMed ID: 11768771
[TBL] [Abstract][Full Text] [Related]
8. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
Feng B; LaPerle JL; Chang G; Varma MV
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics in the elderly.
Crooks J; O'Malley K; Stevenson IH
Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
[TBL] [Abstract][Full Text] [Related]
10. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
Spruill WJ; Wade WE; Cobb HH
Am J Geriatr Pharmacother; 2008 Aug; 6(3):153-60. PubMed ID: 18775390
[TBL] [Abstract][Full Text] [Related]
11. Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged.
Fliser D; Bischoff I; Hanses A; Block S; Joest M; Ritz E; Mutschler E
Eur J Clin Pharmacol; 1999 May; 55(3):205-11. PubMed ID: 10379636
[TBL] [Abstract][Full Text] [Related]
12. The intact nephron hypothesis as a model for renal drug handling.
Pradhan S; Duffull SB; Walker RJ; Wright DFB
Eur J Clin Pharmacol; 2019 Feb; 75(2):147-156. PubMed ID: 30298363
[TBL] [Abstract][Full Text] [Related]
13. The neonatal kidney: implications for drug metabolism and elimination.
Ligi I; Boubred F; Grandvuillemin I; Simeoni U
Curr Drug Metab; 2013 Feb; 14(2):174-7. PubMed ID: 22935066
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
Morgan DJ; McLean AJ
Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
[TBL] [Abstract][Full Text] [Related]
15. Renal Transporter-Mediated Drug-Drug Interactions: Are They Clinically Relevant?
Lepist EI; Ray AS
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S73-81. PubMed ID: 27385181
[TBL] [Abstract][Full Text] [Related]
16. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
Perri D; Ito S; Rowsell V; Shear NH
Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
[TBL] [Abstract][Full Text] [Related]
17. Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.
Matzke GR; Frye RF
Drug Saf; 1997 Mar; 16(3):205-31. PubMed ID: 9098657
[TBL] [Abstract][Full Text] [Related]
18. Factors contributing to variability in drug pharmacokinetics. IV. Renal excretion.
Regårdh CG
J Clin Hosp Pharm; 1985 Dec; 10(4):337-49. PubMed ID: 3912409
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions at the renal level. Implications for drug development.
Bonate PL; Reith K; Weir S
Clin Pharmacokinet; 1998 May; 34(5):375-404. PubMed ID: 9592621
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
Anderson GD
Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
